On the recordApril 6, 2014
H.R. 4299, which seeks to improve the transparency and consistency of DEA's scheduling of new FDA-approved drugs.
Source
congress.govH.R. 4299, which seeks to improve the transparency and consistency of DEA's scheduling of new FDA-approved drugs.
Pitts explains a bill aimed at enhancing drug scheduling transparency.
Share
More from Joe Pitts
Explicitly creating a program exclusively for catfish seems to be unnecessary, and it directs resources away from high-risk foods.
It is unfortunate that we have a Congress of the United States, the majority parties that want to just tear down this law.
Both the FDA and the General Accountability Office agree that there is no food safety justification for this regulatory divide.